Analytical Similarity Assessment in Biosimilar Product Development
Σχετικά με το ebook
Σχετικά με τον συγγραφέα
Author
Shein-Chung Chow, Ph.D, is currently an Associate Director at Office of
Biostatistics, Center for Drug Evaluation and Research, United States Food
and Drug Administration (FDA). Prior to joining FDA, Dr. Chow was a
Professor at Duke University School of Medicine, Durham, NC. He was
also a special government employee (SGE) appointed by the FDA as an
Advisory Committee member and statistical advisor to the FDA. Prior to
that, Dr. Chow also held various positions in the pharmaceutical industry
such as Vice President at Millennium, Cambridge, MA, Executive Director at
Covance, Princeton, NJ, and Director and Department Head at Bristol-Myers
Squibb, Plainsboro, NJ. Dr. Chow is the Editor-in-Chief of the Journal of
Biopharmaceutical Statistics and the Editor-in-Chief of the Biostatistics Book Series
at Chapman and Hall/CRC Press, Taylor & Francis Group. He was elected
Fellow of the American Statistical Association and an elected member of the
ISI (International Statistical Institute). Dr. Chow is the author or co-author of
over 300 methodology papers and 29 books including Designs and Analysis
of Bioavailability and Bioequivalence Studies, Sample Size Calculations in Clinical
Research, Adaptive Design Methods in Clinical Trials, Translational Medicine,
Design and Analysis of Clinical Trials, and Quantitative Methods for Traditional
Chinese Medicine Development.
